ArKal Medical Obtains $17,500,000 Series B Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=82aed883-61fc-4bdd-854c-3de4f04eee0f&Preview=1 -
Date
9/16/2008 -
Company Name
ArKal Medical -
Mailing Address
46575 Fremont Blvd Fremont, CA 94538 -
Company Description
ArKal Medical is developing a novel continuous glucose monitoring system for the management of diabetes. ArKal’s monitoring system is designed to eliminate many of the inconveniences of current glucose monitoring technologies. -
Website
http://www.arkalmed.com -
Transaction Type
Venture Equity -
Transaction Amount
$17,500,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Thomas, McNerny & Partners -
Venture Investor
Delphi Ventures -
Venture Investor
Medventure Associates
